CpG
oligodeoxynucleotides (or CpG ODNs) as Vaccine Adjuvant and ELISA
kits
CpG
oligodeoxynucleotides (or CpG ODN) DNA
molecules that contain an unmethylated CG (Cytosine-guanine) di nucleotide
in a specific base sequence (CpG motifs). The p refers to the
phosphodiester backbone. CpG oligodeoxynucleotides (ODNs) represent a
novel pharmacotherapeutic class with profound immunomodulatory properties.
These CpG motifs are not seen in eukaryotic DNA, in which CG dinucleotides
are suppressed and, when present, usually methylated, due to this they are
considered pathogen-associated molecular patterns (PAMPs). The CpG PAMP is
recognized by the pattern recognition receptor (PRR) Toll-Like Receptor 9
(TLR9), which is constitutively expressed only in B cells and plasmacytoid
dendritic cells (pDCs) in humans and other higher primates. Unmethylated
CpG ODNs (18-24 bp in length) possess immunomodulatory properties similar
to bacterial DNA and they act as immuno stimulants. The immunostimulatory
properties of CpGs include induction of a Th1-type response with prominent
release of IFN-&alpha, IL-12, and IL-18.
Synthetic CpG have a partially or completely
phosphorothioated backbone instead of the typical phosphodiester backbone
and a poly G tail at the 3' end, 5' end, or both. Numerous sequences have
been shown to stimulate TLR9 with variations in the number and location of
CpG dimers, as well as the precise base sequences flanking the CpG dimers.
CpG ODNs are classified into 5 classes, based on their sequence, secondary
structures, and effect on human peripheral blood mononuclear cells
(PBMCs). The five classes are Class
A (Type D), Class B (Type K), Class C, Class P, and Class S
Three major classes of immunostimulatory CpG-ODNs are well characterized
according to their in vitro activities and chemical compositions. Class
A stimulate the production of large amounts of Type I
interferons, the most important one being IFNα, and induce the maturation
of pDCs. They are also strong activators of NK cells through indirect
cytokine signaling. Class
B ODN are strong stimulators of human B cell and monocyte
maturation. They stimulate the maturation of pDC to a lesser extent than
Class A ODN and very small amounts of IFNα. Class
C ODN combine features of both types A and B. They contain
a complete phosphorothioate backbone and a CpG-containing palindromic
motif. They induce strong IFN-α production from pDC and B cell
stimulation.
Several groups have studied the sequence requirements,
specificity, signaling pathways and kinetics of the TLR (Toll-like
receptor) 9 suppression by 'inhibitory
DNA motifs', which led to a revised classification of inhibitory
ODNs. Class I: G-stretch ODNs: TLR9-specific
competitors, some iODNs may also affect TLR7 and TLR8 signaling. Class II:
ODNs with telomeric repeats: TLR-independent inhibitors of STAT signaling
(cellular uptake via an "ODN receptor"?) Class
III: Inhibitors of DNA uptake in a sequence independent manner
Class
IV: Long phosphorothioate ODNs as direct competitors of TLR9
signaling in a sequence independent manner.
Product
ordering Information (Data sheets and Prices are posted at the
website)
Items |
Description |
TLR Type |
Unlabeled Cat
# |
Biotin
Conj. Cat
# |
Negative
Control* |
ODN1585 |
ODN
1585-Type A murine TLR9 agonist, Antigen grade; 5'-ggGGTCAACGTTGAgggggg-3' (20
mer)
|
Murine
TLR9 agonist |
ODN1585-1
ODN1585-5 |
ODN1585-B |
ODN1585-1NC
ODN1585-5NC |
ODN
1668 |
ODN
1668- Type B murine TLR9 Agonist, Antigen grade; 5'-tccatgacgttcctgatgct-3' (20 mer)
|
Murine
TLR9 agonist |
ODN1668-1
ODN1668-5 |
ODN1668-B
|
ODN1668-1NC
ODN1668-5NC |
ODN
1826
|
ODN
1826- Type B murine TLR9 Agonist, antigen grade; 5'-tccatgacgttcctgacgtt-3' (20 mer)
|
Murine
TLR9 agonist |
ODN1826-1
ODN1826-5 |
ODN1826-B
|
ODN1826-1NC
ODN1826-5NC |
ODN
2006 |
ODN
2006 -Type B-human TLR9 agonist, antigen grade; 5'-tcgtcgttttgtcgttttgtcgtt-3' (24 mer)
|
Human
TLR9 agonist |
ODN2006-1
ODN2006-5 |
ODN2006-B
|
ODN2006-1NC
ODN2006-5NC |
ODN
2007 |
ODN
2007-Type B bovine/porcine TLR9 agonist, antigen grade; 5'-tcgtcgttgtcgttttgtcgtt-3' (22 mer)
|
Bovine
TLR9 agonist |
ODN2007-1
ODN2007-5 |
ODN2007-B |
ODN2007-1NC
ODN2007-5NC |
ODN
2216 |
ODN
2216-Type A human TLR9 Agonist, antigen grade, 5'-ggGGGACGATCGTCgggggg-3'(20
mer)
|
Human
TLR9 agonist |
ODN2216-1
ODN2216-5 |
ODN
2216-B |
ODN
2216-1NC
ODN
2216-5NC |
ODN
2336 |
ODN
2336-Type A human specific TLR 9 agonist, antigen grade;
5'-gggGACGACGTCGTGgggggg -3' (21
mer) |
Human
TLR9 agonist |
ODN2336-1
ODN2336-1 |
ODN2336-B |
ODN2336-1NC
ODN2336-5NC |
ODN
2395 |
ODN
2395-Type C human/murine TLR9 agonist, antigen grade. 5' tcgtcgttttcggcgcgcgccg-3' (22 mer) |
Human
TLR9 agonist |
ODN2395-1
ODN2395-5 |
ODN2395-B
|
ODN2395-1NC
ODN2395-1NC |
ODN
M362 |
ODN
M362-Type C human/murine TLR9 agonist, antigen grade; 5'-tcgtcgtcgttcgaacgacgttgat-3' (25
mer) |
Human
TLR9 agonist |
ODNM362-1
ODNM362-1 |
ODNM362-B |
ODNM362-1NC
ODNM362-5NC |
AT-ODN-1 |
AT
ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade. 5'-tataattttaatttccaaga-3' (20
mer) |
TLR9
agonist |
ATODN1-1
|
4 |
4 |
AT-ODN-2 |
AT
ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade 5'-tataatttttaccaactagc-3' (22
mer) |
TLR9
agonist |
ATODN2-1
|
4 |
4 |
AT-ODN-2 |
AT
ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade; 5'-ttaacaatttttacccaaga-3' (22
mer) |
TLR9
agonist |
ATODN3-1
|
4 |
4 |
Neutral
ODN |
Control
for inhibitory ODNs. No agonistic or Antagonist activity, Antigen
grade;
5'-tgctcctggaggggttgt-3' (18 mer)
|
Control |
ODN-NT-1 |
4 |
4 |
ODN
BW006 |
ODNBW006
CpG ODN (contains structure type B sequence at 5' and Type A at the
3' end), antigen grade; 5'-tcgacgttcgtcgttcgtcgttc-3' (23 mer) |
|
ODN006-1 |
4 |
4 |
CpG
oligodeoxynucleotides (or CpG ODNs) as Vaccine Adjuvant and ELISA kits
Items |
Description |
TLR
Type |
Unlabeled
Cat
# |
Biotin
Conj.
Cat
# |
Negative
Control* |
ODN
2088 |
ODN
2088- Class I Murine TLR9 Antagonist, antigen grade;
5'-tcctggcggggaagt-3' (15 mer)
|
Murine
TLR9 Antagonist |
ODN2088-1
ODN2088-1
|
4 |
ODN2088-1
ODN2088-1 |
ODN
4084-F |
ODN
4084-Type B Inhibitory TLR9 Antagonist, antigen grade;
5'-cctggatgggaa-3' (15 mer)
|
TLR9
Antagonist |
ODN4084F-1
ODN4084F-5 |
4 |
ODN4084F-1
ODN4084F-5 |
ODN
INH-1 |
ODN
INH-1 -Class R (restricted) inhibitory ODN-TLR 9 Antagonist, antigen
grade; 5'-cctggatgggaattcccatccagg-3' (23mer)
|
TLR9
Antagonist |
ODNIHN1-1 |
4 |
4 |
ODN
INH-47 |
ODN
INH-47- Class R (restricted) inhibitory ODN-TLR 9 Antagonist,
antigen grade, 5'-tatggattttaattaaaatccata-3'
(23mer)
|
TLR9
Antagonist |
ODNINH47-1 |
4 |
4 |
ODN
TTAGGG |
ODN
TTAGGG-Inhibitory ODN
Human TLR9 antagonist, Antigen grade;
5'-tttagggttagggttagggttaggg-3' (25 mer)
|
Human
TLR9 antagonist |
ODNTT-1 |
4 |
ODNTT-1NC |
G-ODN |
G-ODN
Murine TLR9 antagonist, Antigen grade; 5'-ctcctattgggggtttcctat-3'
(21 mer)
|
Murine
TLR9 antagonist |
GODN-1 |
4 |
4 |
Core-iODN |
Inhibitory
ODN class I prototype (TLR7 and TLR8), antigen grade;
5'-tcctggagggg-3' (11mer)
|
TLR9
and TLR7 antagonist |
CIODN-1 |
4 |
4 |
Super-iODN |
Inhibitory
ODN- class I/II hybrid (TLR7 and TLR8), antigen grade,
5'-cctcaatagggtgagggg-3' (18mer)
|
TLR9
and TLR7 antagonist |
SIODN-1 |
4 |
4 |
Dual-iODN |
Inhibitory
ODN-prototype class I (TLR9 and TLR7 antagonist), antigen grade;
5'-tgctcctggaggggttgt-3' (18mer)
|
TLR9
and TLR7 antagonist |
DIODN-1 |
4 |
4 |
Notes: 1.
Bases in capital are phosphodiester and those in lower case are phosphorothioate. Palindromic sequences are underlined. 2. Bases depicted in italics show AT-ODN sequence. 3. Negative control contains GpC nucleotides instead of CpG. 4. Contact ADI to place a special order for Biotin or FITC Conjugates.
ELISA Kits for the study of Adjuvant effect on antibody response
The main function of adjuvants (conventional oil-based, special formulation or ODNs) is to enhance antibody response to a given antigen. The antibody levels or titer in the host species (mouse, rat, rabbit, G. pig, Ferret, Hamster, monkey or human etc) is typically measure by ELISA. ADI provides several species specific ELISA kits to measure antibody titer. These kits contain all necessary reagents, except user's specific antigen, for about 1000 tests. Please contact us for details.
We also have ELISA kit for IgG, IgM, IgA, IgE or individual IgG isotypes (IgG1, 2a, 2b, IgG3) in serum or plasma for mouse, rat, human etc
ELISA Kits for the study of Adjuvant effect on anbtibody response using model antigens
Several model proteins have been used as model antigens (Bovine serum albumin/BSA or HSA, ovalbumin or OVA, Keyhole limpet hemocyanins/KLH, thyroglobulin, DNP-KLH/Albumin or Tetanus Toxoid or TTX or Diptheria Toxoids. Adjuvants (conventional or ODN-based) have been used to study antibody response to a model antigen in a given species of host. We have specific antibody ELISA kits for these model antigens.
ELISA Kits to measure ODN-induced anti-dsDNA or anti-ssDNA anbtibody
It is possible that some DNA-sequences (ODNs) when used as adjuvant may invoke anti-DNA antibodies. The presence of absence of anti-DNA antibodies must be investigated if any ODNs is intended for vaccines.
|